DataCloudKnowledgetrainingcoordination

L1000 LINCS DCIC FIBR031 MCLF054CN 6H I17 alprostadil 4uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF054CN

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR031 MCLF054CN 6H I17 alprostadil 4uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:190 KB

Size In Bytes:89.3 KB

Sha256:f1884a20459c5c3033360aa85bed6f45bb8481a24e5d767ce7c310939de8dff5

Persistent Id:drs://drs.lincs-dcic.org/fb887a6969c0e762d9d99959f436656b

Mime Type:application/gzip

Md5:fb887a6969c0e762d9d99959f436656b

Filename:L1000_LINCS_DCIC_FIBR031_MCLF054CN_6H_I17_alprostadil_4uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/fb887a6969c0e762d9d99959f436656b

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR031 MCLF054CN 6H I17 alprostadil 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR031 MCLF054CN 6H I17 alprostadil 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.